Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus

BACKGROUND: Direct-acting antiviral agents (DAAs) permit the use of interferon (IFN)-free regimens to treat hepatitis C (HCV) in patients with chronic kidney disease (CKD) on hemo-dialysis (HD) or renal transplant (RTx) recipients, with excellent response rates and safety. However, the occurrence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavares, Rita Chelly Felix, de Castro Amaral Feldner, Ana Cristina, Pinho, João Renato Rebello, de Mello Malta, Fernanda, Carvalho-Filho, Roberto José, Santana, Rúbia Anita Ferraz, de Castro, Vanessa Fusco Duarte, Dastoli, Gregório Tadeu Fernando, Lima, Juliana Custódio, Ferraz, Maria Lucia Cardoso Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208931/
https://www.ncbi.nlm.nih.gov/pubmed/30464541
http://dx.doi.org/10.2147/IDR.S169512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208931/
https://www.ncbi.nlm.nih.gov/pubmed/30464541
http://dx.doi.org/10.2147/IDR.S169512

Ejemplares similares